wr 99210 has been researched along with hypoxanthine in 1 studies
| Studies (wr 99210) | Trials (wr 99210) | Recent Studies (post-2010) (wr 99210) | Studies (hypoxanthine) | Trials (hypoxanthine) | Recent Studies (post-2010) (hypoxanthine) |
|---|---|---|---|---|---|
| 59 | 0 | 12 | 2,529 | 65 | 361 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fidock, DA; Nomura, T; Wellems, TE | 1 |
1 other study(ies) available for wr 99210 and hypoxanthine
| Article | Year |
|---|---|
Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
Topics: Animals; Antimalarials; Folic Acid Antagonists; Genetic Complementation Test; Humans; Hypoxanthine; Inhibitory Concentration 50; Methotrexate; Mutation; Plasmodium falciparum; Proguanil; Tetrahydrofolate Dehydrogenase; Triazines | 1998 |